cardiovascular system
• increase in cross-sectional area of cardiac myocytes
|
• ventricular/body weight ratio is increased, indicating cardiac hypertrophy
• molecular markers of cardiac hypertrophy (Myh7 and Nppb) are increased
|
• mice exhibit left ventricular hypertrophy as indicated by increased interventricular septal thickness and left ventricular mass
|
• increase in posterior wall thickness
|
• 2-fold increase in interstitial fibrosis
• molecular markers of fibrosis (Co1a1 and Col3a1) are increased
|
• left ventricular end diastolic diameter is moderately increased and mitral inflow is increased
• however left ventricular systolic function is normal
|
muscle
• increase in cross-sectional area of cardiac myocytes
|
• mice exhibit left ventricular hypertrophy as indicated by increased interventricular septal thickness and left ventricular mass
|
• various Z disk abnormalities, including poorly formed Z disks associated with myofibrillar disarray, and interrupted, discontinuous, bulging and slipped Z disks
|
growth/size/body
• ventricular/body weight ratio is increased, indicating cardiac hypertrophy
• molecular markers of cardiac hypertrophy (Myh7 and Nppb) are increased
|
• mice exhibit left ventricular hypertrophy as indicated by increased interventricular septal thickness and left ventricular mass
|
cellular
• 2-fold increase in interstitial fibrosis
• molecular markers of fibrosis (Co1a1 and Col3a1) are increased
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
hypertrophic cardiomyopathy 16 | DOID:0110322 |
OMIM:613838 |
J:210073 |